These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17572094)

  • 1. SAR study of bicyclo[4.1.0]heptanes as melanin-concentrating hormone receptor R1 antagonists: taming hERG.
    Su J; McKittrick BA; Tang H; Burnett DA; Clader JW; Greenlee WJ; Hawes BE; O'Neill K; Spar B; Weig B; Kowalski T; Sorota S; Li C; Liu T
    Bioorg Med Chem; 2007 Aug; 15(16):5369-85. PubMed ID: 17572094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists.
    Xu R; Li S; Paruchova J; McBriar MD; Guzik H; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar BD; Weig B; Weston DJ
    Bioorg Med Chem; 2006 May; 14(10):3285-99. PubMed ID: 16442800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
    Hertzog DL; Al-Barazanji KA; Bigham EC; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Daniels AJ; Garrido DM; Goetz AS; Grizzle MK; Guo YC; Handlon AL; Ignar DM; Morgan RO; Peat AJ; Tavares FX; Zhou H
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4723-7. PubMed ID: 16870432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
    Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR study of pyrrolo[3,4-b]pyridin-7(6H)-one derivatives as melanin concentrating hormone receptor 1 (MCH-R1) antagonists.
    Lim CJ; Kim JY; Lee BH; Oh KS; Yi KY
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1736-9. PubMed ID: 23411080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists.
    Su J; Tang H; McKittrick BA; Gu H; Guo T; Qian G; Burnett DA; Clader JW; Greenlee WJ; Hawes BE; O'neill K; Spar B; Weig B; Kowalski T; Sorota S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4845-50. PubMed ID: 17604169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
    McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
    J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis.
    Su J; McKittrick BA; Tang H; Czarniecki M; Greenlee WJ; Hawes BE; O'Neill K
    Bioorg Med Chem; 2005 Mar; 13(5):1829-36. PubMed ID: 15698800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.
    Sweis RF; Hunt JA; Sinclair PJ; Chen Y; Eveland SS; Guo Q; Hyland SA; Milot DP; Cumiskey AM; Latham M; Rosa R; Peterson L; Sparrow CP; Anderson MS
    Bioorg Med Chem Lett; 2011 May; 21(9):2597-600. PubMed ID: 21398121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.
    Mihalic JT; Fan P; Chen X; Chen X; Fu Y; Motani A; Liang L; Lindstrom M; Tang L; Chen JL; Jaen J; Dai K; Li L
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3781-5. PubMed ID: 22542010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4274-9. PubMed ID: 19500982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead optimization of melanin concentrating hormone receptor 1 antagonists with low hERG channel activity.
    Judd AS; Souers AJ; Kym PR
    Curr Top Med Chem; 2008; 8(13):1152-7. PubMed ID: 18782010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.
    Kasai S; Kamata M; Masada S; Kunitomo J; Kamaura M; Okawa T; Takami K; Ogino H; Nakano Y; Ashina S; Watanabe K; Kaisho T; Imai YN; Ryu S; Nakayama M; Nagisa Y; Takekawa S; Kato K; Murata T; Suzuki N; Ishihara Y
    J Med Chem; 2012 May; 55(9):4336-51. PubMed ID: 22490048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability.
    Moorjani M; Zhang X; Chen Y; Lin E; Rueter JK; Gross RS; Lanier MC; Tellew JE; Williams JP; Lechner SM; Malany S; Santos M; Ekhlassi P; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Saunders J; Slee DH
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1269-73. PubMed ID: 18249540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 4-(dimethylamino)quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1.
    Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Beeley N; Sekiguchi Y
    Bioorg Med Chem Lett; 2005 May; 15(10):2565-9. PubMed ID: 15863317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanin concentrating hormone receptor antagonists as antiobesity agents: from M2 to MCHR-1.
    McBriar MD
    Curr Top Med Chem; 2007; 7(15):1440-54. PubMed ID: 17897031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.